1. Introduction {#s0005}
===============

Lipidomics has wide implications for human health. Among the most fundamental roles for lipids is their participation in cell membranes, where they serve not only structural but also dynamic functions. Current understanding of cell membrane organization postulates the existence of lipid microdomains, or rafts, comprised principally of cholesterol and sphingolipids, which self-segregate from the surrounding phospholipid bilayer [@bib1] due to sterically aversive forces [@bib2]. The largely dietarily-determined lipid balance can affect the physicochemical properties of the membrane microdomains, with downstream effects on cell-cell signaling, molecular trafficking, and regulation of transmembrane proteins, including a variety of transporters and G-protein coupled receptors [@bib3]. Among technologies used to study the composition of lipid rafts, ^1^H detected high-resolution magic-angle spinning nuclear magnetic resonance (HRMAS NMR) utilizes the natural proton signals from lipids to provide very good resolution of chemically shifted resonances through rapid spinning of samples at the "magic angle" (54.7°) with respect to the main magnetic field. NMR has been used to characterize lipid rafts in model membrane systems [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], in cell culture [@bib14], [@bib15], [@bib16], and in the influenza viral envelope [@bib17]. However, NMR has not been utilized in clinical studies of human cell membranes. Therefore we proceeded to test the feasibility of using HRMAS NMR to characterize lipid rafts in human platelets, in which lipid rafts have been successfully studied using other methods [@bib18], [@bib19], [@bib20], [@bib21]. The NMR approach allows for physicochemical characterization of lipid rafts at the molecular level. Potential applications include studies of the effects of dietary intake of lipids (e.g., polyunsaturated fatty acids and cholesterol) and antihyperlipidemic medications on cell membrane functioning in healthy individuals and in pathological states.

2. Materials and methods {#s0010}
========================

2.1. Sample {#s0015}
-----------

Platelets were isolated from plasma of medication-free adult research participants (*n*=13) with major depressive disorder who were otherwise medically healthy, and who had enrolled in mood disorders protocols at the New York State Psychiatric Institute and gave informed consent to the collection of blood samples for biochemical studies.

2.2. Purification of platelet lipid domains {#s0020}
-------------------------------------------

Platelets were extracted from blood samples as previously described according to methods optimized by our research team [@bib22]. Briefly, the blood was collected in EDTA vacutainer tubes and centrifuged at low speed to obtain the platelet-rich-plasma, which was then further centrifuged (12,000×*g*, 4 °C, 4 min). The resulting pellets were resuspended in 5 mL of ice-cold phosphate-buffered saline (PBS, pH 7.4) and again pelleted and stored at −80 °C until used. For the next (homogenization) step, the platelet pellets were resuspended and washed twice in ice-cold PBS and suspended in 2 mL of 500 mM Na~2~CO~3~ solution, pH 11.0.

To avoid artifacts associated with detergent extraction [@bib23], [@bib24], lipid rafts were isolated from extracted platelets using non-detergent methods: cells were lysed using a Polytron Homogenizer (Brinkmann, Lucerne, Switzerland; three 10-s bursts at setting 3) and then subjected to sonication with an XL-2000 Ultrasonic Cell Disruptor (Microson, Newtown, CT, USA; three 20-s bursts at setting 5). The homogenate was then adjusted to 45% sucrose by adding 2 mL of 90% sucrose prepared in 25 mM MES-buffered saline (MBS; 25 mM 2-(*N*-morpholino)ethanesulfonic acid, pH 6.5, 0.15 M NaCl). The fraction enriched in lipids was isolated by a 5--35% discontinuous sucrose gradient \[5%, 15%, 25%, 35%\], followed by ultracentrifugation (100,000×*g* for 20 h at 4 °C) with flotation (adapted from [@bib25]). Fractions containing lipids exhibited visible opalescence after ultracentrifugation ([Fig. 1](#f0005){ref-type="fig"}A). The interface was removed, diluted with 2X MBS buffer, and centrifuged (10,000 rpm for 20 min); the pellets were saved and stored at −20 °C for subsequent lipid extraction. The presence of GM1 gangliosides in the lipid fraction was assessed with GM1-specific horseradish peroxidase (HRP)-conjugated cholera toxin B subunit dot blot assays [@bib26] using chemiluminescence ([Fig. 1](#f0005){ref-type="fig"}B). The quantity of proteins in lipid and non-lipid fractions was determined by Bicinchoninic (BCA) Protein Assay (Thermo Fisher Scientific; Rockford, IL, USA) [@bib27] and spectrophotometry ([Fig. 1](#f0005){ref-type="fig"}C). The Folch method [@bib28] was used to extract the lipids from the sucrose solution into an 8:4:3 chloroform-methanol-water mixture. Lipid samples were lyophilized and stored at −80 °C.Fig. 1Purification and validation of lipid rafts from human platelets. **A.** Visible opalescent lipid band with respect to the sucrose fractionation. **B.** GM1-specific HRP-conjugated cholera toxin B subunit dot blot assays. **C.** BCA assay differentiates between lipid-associated (fraction 4) and lipid non-associated (fraction 9) proteins; 'n.d.' indicates no protein detected.Fig. 1

2.3. Lipid ^1^H HRMAS NMR spectra {#s0025}
---------------------------------

To prepare samples for NMR, the frozen lyophilized lipids were reconstituted in deuterated water (D~2~O). Five washes in D~2~O were each performed by adding 300 µL of deuterated water to each sample in a microcentrifuge tube, spinning the samples at 10,000 rpm for 15 min, and decanting the clear layer using a pipette. Between each wash, samples were frozen via direct contact of the outside of the microcentrifuge tube with dry ice and thawed at room temperature followed by gentle vortexing. These freeze-thaw cycles were performed in order to facilitate H/D exchange between the solvent and membrane fragments. Samples thus prepared for HRMAS NMR were slightly viscous and visibly, uniformly opaque suspensions of multibilayers.

Butylated hydroxytoluene (BHT) was added to all samples to prevent oxidation of the unsaturated lipid acyl chains. Water-soluble 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was added to all samples at a ratio of 100:1 lipid:DSS by weight as a chemical shift calibration standard for NMR spectroscopy.

NMR data were acquired at the New York Structural Biology Center on a 4-channel Bruker Avance I widebore spectrometer equipped with a 4 mm HRMAS HCND probe and ZrO~2~ rotors (Bruker Biospin, Karlsruhe, Germany), operating at a ^1^H resonance frequency of 750 MHz and using a spectral width of 15 kHz. Samples were spun at an angle of 54.7° to the magnetic field direction (the 'magic angle') at spinning frequencies of 4--5 kHz to obtain well-resolved spectra. ^1^H spectra were acquired with a single-pulse Bloch decay experiment [@bib29] using an 8 μs 90° pulse. We acquired 128 scans with a recycle delay of 2 s between data acquisitions, thus requiring \~4 min to obtain each spectrum. The signal-to-noise ratio for the main lipid resonance was 50:1, allowing for reliable estimates of peak intensity and linewidth at half height. A presaturation water suppression technique was used to suppress the signal from residual ^1^H nuclei in the D~2~O solvent. Experiments were executed with and without a pre-acquisition echo sequence to test for the presence of broad signals [@bib30]. Measurement temperatures were varied from −10 °C to 35 °C and calibrated with a methanol standard [@bib31]. Sideband / centerband intensity ratios and linewidth differences of the principal lipid resonance at \~1.3 ppm were monitored *vs.* temperature, and these ratios were used to validate the presence of rafts in the L~o~ phase [@bib12].

Rates of lipid lateral diffusion (signal intensity decay as a function of time) were measured in a two-dimensional stimulated echo longitudinal encode-decode experiment conducted with presaturation and bipolar gradients [@bib32] (256 scans, gradient length 8 μs, recycle delay 2 s, gradient strengths of 2--96% in 32 steps (1 G/cm--48 G/cm), 1500 μs delay based on the length of the gradient pulse, diffusion time 100 ms).

3. Results {#s0030}
==========

3.1. Purification of lipid microdomains {#s0035}
---------------------------------------

On sucrose gradient fractionation, a distinct opalescent band was visualized between 5% and 35% sucrose density, in fractions 3--5 ([Fig. 1](#f0005){ref-type="fig"}A), and the presence of lipid rafts was supported by GM1 ganglioside-positive dot blots in the same fractions ([Fig. 1](#f0005){ref-type="fig"}B). Chemiluminescence results ([Fig. 1](#f0005){ref-type="fig"}B) revealed that lipid fractions were positive for the presence of GM1 gangliosides, which have been associated with lipid raft domains [@bib33]. The BCA assay was consistent with the presence of raft-associated and non-raft-associated proteins, in fractions 4 and 9, respectively ([Fig. 1](#f0005){ref-type="fig"}C).

3.2. Spectroscopic properties of purified platelet lipid fractions {#s0040}
------------------------------------------------------------------

As expected, the most prominent feature in the membrane phospholipid spectrum ([Fig. 2](#f0010){ref-type="fig"}) was the hydrocarbon chain 'bulk' methylene resonance at \~1.3 ppm. No broad spectral contributions were evident in data obtained without the pre-acquisition spin echo sequence, arguing against the presence of residual membrane-associated proteins or lipids in the S~o~ phase. Across the 4 platelet-derived lipid multibilayer samples, we observed linewidth values (full width at half-maximum intensity) for the 'centerband' methylene peak at 1.3 ppm ranging from 55 to 82 Hz at 6.5 °C, with corresponding sideband:centerband ratios amounting to 2.5--5.3%. Compared with small-molecule standards such as DSS, the centerband peak thus exhibits a clearly broadened resonance. Nonetheless, these relatively modest centerband linewidths and sideband proportions, together with the similarity in magnitude of the linewidths for the (CH~2~)~n~ centerband and sideband (shown in [Fig. 2](#f0010){ref-type="fig"}), are more characteristic of the liquid-ordered (L~o~) phase identified with lipid rafts in equilibrium with a liquid-disordered (L~d~) phase [@bib6] than with a significant S~o~ component. Our findings are also consistent with reports of model membrane systems in which raft formation accompanied by enhanced membrane order has been associated with greater proportions of cholesterol with respect to phospholipid, producing a modestly broadened centerband peak and minor redistribution of the signal intensity from centerband to sidebands [@bib4].Fig. 2Representative platelet lipid NMR spectra. From this experiment, acquired at 6.5 °C, two contributions to the lipid chain methylene resonance (CH~2~)~n~ are visible: centerband, 1.3 ppm (top arrow) and one spinning sideband, 8 ppm (left arrow) are shown. The internal chemical shift calibration standard, 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) has two peaks (small arrows). HOD denotes H~2~O in equilibrium with D~2~O.Fig. 2

3.3. Phase transitions and raft formation demonstrated through ^1^H NMR spectra at varying temperatures {#s0045}
-------------------------------------------------------------------------------------------------------

A temperature series ([Fig. 3](#f0015){ref-type="fig"}) provides information about the phase transition between the L~d~ and L~o~ phases of our lipid-enriched platelet preparation. Decreasing height of the 1.3-ppm peak in response to decreasing temperature ([Fig. 3](#f0015){ref-type="fig"}A), which is accompanied by an increase in peak linewidth, is most simply explained by an increased predominance of L~o~ relative to L~d~ phase of the membranes [@bib5]. In a more quantitative presentation of the data ([Fig. 3](#f0015){ref-type="fig"}B), the intensity of the 1.3-ppm peak is illustrated as a function of temperature; a discontinuity is apparent at higher temperatures, from which we estimate an L~d~-to-L~o~ transition temperature of approximately 18 °C.Fig. 3Temperature dependence of peak intensity. A. Phospholipid chain methylene (1.2--1.4 ppm) spectral region for a series of ^1^H HRMAS NMR spectra of platelet lipids acquired in a single sample at temperatures between −20 °C and 32 °C. B. Using data from A, (CH~2~)~n~ peak signal intensities at 1.3 ppm, as a percentage of the total intensity across the spectrum, are plotted as a function of temperature. A discontinuity is apparent at higher temperatures; extrapolation of the two straight-line portions yields an intersection point from which the apparent L~d~ to L~o~ phase transition temperature is estimated to be \~18 °C.Fig. 3

3.4. Diffusion as a measure of average domain size {#s0050}
--------------------------------------------------

The dependence of peak intensity on gradient strength is a measure of the translational diffusion constant. Diffusion is spatially restricted if the average distance that lipids move during the diffusion time is constant for a sufficiently long period. We extracted an order-of-magnitude diffusion constant of 1.4×10^--11^ m^2^/s, a measure of average domain size that is in reasonable agreement with the 0.8×10^--11^ value reported previously for a model phospholipid mixture [@bib4]. As expected, the acyl chain lipid signal at 1.3 ppm decayed more slowly with gradient strength than the reference DSS signals ([Fig. 4](#f0020){ref-type="fig"}). The membrane microdomain size indicated by the approximately three-fold lower rates of lateral diffusion we observed in comparison to the freely mobile water-soluble DSS standard is consistent with the scale estimated for lipid rafts in phospholipid model membrane mixtures [@bib4].Fig. 4Representative lipid diffusion study. This 3-D graph illustrates the methylene resonance at 1.3 ppm as a function of gradient strength. Arrows indicate decay of the lipid raft signal, which occurs approximately 3 times more slowly with gradient strength than the 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) standard (large twin peaks flanking the methylene signal).Fig. 4

4. Discussion {#s0055}
=============

In platelet-derived lipid rafts, we obtain reproducible, well-resolved lipid HRMAS ^1^H NMR spectra with minimal artifacts. Our observed linewidths, intensity ratios, and preferential broadening of sidebands agree well with values reported for lipid rafts in 30 mol% cholesterol mixtures with a single phospholipid such as 1-stearoyl-2-oleoylphosphatidylcholine [@bib12]. We have also successfully measured lateral lipid diffusion, and we consider this estimate to be compatible with that previously reported for phospholipid mixtures in a model membrane preparation [@bib4], given the different compositions of the respective lipid mixtures and our observation of biexponential signal decays. Our phase transition results, derived from a temperature series, can be compared with those of Veatch et al. [@bib5], who studied a mixture of 30% cholesterol and 70% phosphatidylcholine (PC) phospholipids (dioleoylphosphatidylcholine \[DOPC\] + dipalmitoylphosphatidylcholine \[DPPC\]). Our clinical samples are expected to approximate this distribution, since human platelets are about 20% cholesterol and 70% phospholipid. The largest phospholipid fraction, \~35%, is PC, although phosphatidylinositol (\~10%), phosphatidylserine (\~12%), phosphatidylethanolamine (\~22%) and sphingomyelin (\~15%) are also present [@bib34]. The shape of our phase transition curve ([Fig. 3](#f0015){ref-type="fig"}) resembles that of Veatch et al. [@bib5], except the platelet membrane data are shifted to the left. The 30:70 cholesterol:PC phospholipids model membranes exhibit a L~o~-to-L~d~ transition temperature of \~32 °C for the binary lipid mixture [@bib5], consistent with the presence of high-melting DPPC, in contrast to an apparent L~o~-to-L~d~ transition temperature of \~18 °C for our more complex mixture that includes phospholipid species with unsaturated acyl chains. By comparison, Fourier transform infrared spectroscopy (FT-IR) methods show phase transitions at \~15 and \~30 °C for intact platelets prepared without lipid enrichment [@bib35].

We acknowledge that the demonstration of phase transition is not proof that functional rafts exist in the extracted fractions. In the following section we discuss combining NMR studies with biological assays to verify the presence of rafts by assessing various functional characteristics.

4.1. Potential of NMR as a clinical tool to study lipid rafts in biological membranes {#s0060}
-------------------------------------------------------------------------------------

Because of their renewability, platelets can provide a cost-effective and minimally invasive *ex vivo* method for studying the functions of lipid rafts in humans. Standardized methods for obtaining a detailed platelet lipid raft profile could provide a platform for understanding whether lipid raft changes mediate effects on clinical symptoms. Such methods of valuation may eventually be useful for evaluating the risk of chronic conditions already associated with lipid rafts, including Parkinson\'s disease [@bib36], dementia [@bib37], atherosclerosis [@bib38], [@bib39], rheumatoid arthritis [@bib40], and depression [@bib41], [@bib42].

To approach this goal, lipid raft functional roles in cell signaling [@bib43] and protein trafficking [@bib44] could be studied using NMR measurement of lipid raft physicochemical properties accompanied by dynamic functional studies after perturbation or enhancement of lipid raft characteristics. For instance, lipid raft disruption by cholesterol depletion alters mobility of the serotonin transporter [@bib45], decreases transport activity, and reduces transporter affinity for serotonin [@bib46], [@bib47]. As another example, polyunsaturated fatty acids (PUFAs) have direct effects on the physicochemical properties of plasma membrane lipid subdomains in model membrane systems [@bib2], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], and incorporation of polyunsaturated fatty acids into lipid rafts increases antibody binding to major histocompatibility complex (MHC) class I membrane proteins on certain cell types [@bib48]. These structure-function studies have all been carried out in cell culture [@bib45], [@bib47], [@bib48], [@bib49], heterologous expression systems [@bib46] or animal models [@bib46], [@bib49]. Our NMR technique, however, is designed to be used in studies of human platelets or other cell types. In combination with functional assays, NMR could thus be used to prospectively assess effects of dietary PUFA supplementation or cholesterol-lowering medications on activity of membrane proteins and how changes in activity relate to changes in raft structural properties.

4.2. Limitations {#s0065}
----------------

Potential limitations include artifacts induced by the sucrose gradient and mechanical disruption of membranes, and lack of information about the ganglioside and protein components of the system. We note that NMR spectra were monitored over a limited range of temperatures in this preliminary feasibility study. Additional studies encompassing a greater range of temperatures would be required in order to verify whether other discontinuities also occur.

5. Conclusions {#s0070}
==============

Our findings introduce a novel translational application for a powerful basic science tool. NMR quantification of platelet lipid rafts can enhance other high-resolution and quantitative approaches [@bib50], [@bib51] to the study of structural and functional characteristics of lipid microdomains. This new translational approach could have clinical utility for understanding physiology and pathophysiology at the molecular level.
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